European drug authorities push for stronger warnings on Actos
October 26, 2011
Product Liability
European drug authorities have confirmed an earlier decision not to ban the type 2 diabetes treatment Actos (pioglitazone) even though studies have linked the drug to bladder cancer. The decision goes against the actions of drug regulators in France and ... Read More
IOM report indicates more study of TBI necessary to determine effective treatment
October 26, 2011
Personal Injury
A report released Oct. 11 by the Institute of Medicine (IOM) indicates more study with a larger focus group may be necessary to determine an effective course of treatment for people suffering from Traumatic Brain Injury (TBI). The study was ... Read More
CDC recommends expansion of Gardasil use to boys
October 26, 2011
Pharmaceutical
As expected, a U.S. Centers for Disease Control and Prevention (CDC) advisory committee this week recommended expanding the use of the Gardasil vaccine, manufactured by Merck, to include boys and young men. The vaccine, which targets the human papillomavirus (HPV), ... Read More
New blood test may replace riskier tests for Down syndrome
October 26, 2011
Product Liability
A recently approved prenatal test for Down syndrome may eliminate the need for procedures that put mothers at risk for miscarriage and other complications. Sequenom Inc., a genetic analysis products maker, has launched the MaterniT21 test, which requires only the ... Read More